Jadenu
- Product NDC
- 0078-0713
- 11-digit product format
- 000780713
- Labeler code
- 0078
- Product ID
- 0078-0713_028e6158-3b78-41dd-99a8-6acb582f7245
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA207968
- Marketing category
- NDA
- Marketing start
- 2017-05-18
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Jadenu
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFERASIROX | 180 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V8G4MOF2V9 |
| Rxcui | 1607784, 1607790, 1607792, 1607794, 1607796, 1607798, 1923822, 1923825, 1923826, 1923827, 1923828, 1923829 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0078-0713-15 | Jadenu | 30 in 1 CARTON | GRANULE | 30 | | 26 |
| 0078-0713-19 | Jadenu | 1 in 1 PACKET | GRANULE | 1 | | 26 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DEFERASIROX | ACTIVE INGREDIENT | V8G4MOF2V9 | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| DEFERASIROX | ACTIVE MOIETY | V8G4MOF2V9 | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| POLOXAMER 188 | INACTIVE INGREDIENT | LQA7B6G8JG | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | JADENU (DEFERASIROX) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0078-0713 | JADENU (DEFERASIROX) TABLET, FILM COATED JADENU (DEFERASIROX) GRANULE [NOVARTIS PHARMACEUTICALS CORPORATION] | 23 | Current NDC, Legacy NDC, 2 package rows | 20250503_fee89140-fff1-4443-9f42-24ac004fcda1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0713-15 | 00078071315 | 30 PACKET in 1 CARTON (0078-0713-15) / 1 GRANULE in 1 PACKET (0078-0713-19) | 30 packet | 2017-05-18 | 0000-00-00 | No | No | Current |
| 0078-0713-19 | 00078071319 | 1 in 1 PACKET | | | | | | Historical |